In summary, the ACE2 pathway regulates BAT function and systemic energy metabolisms which is a potential treatment target for metabolic disorders including metabolic syndrome, diabetes, dyslipidemia, and fatty liver. This evidence concerns the gene ACE2 and metabolic disease.